Scott Reents
Patrimonio netto: 10 M $ in data 31/07/2026
Patrimonio netto: 10 M $ in data 31/07/2026
Scott T.
Reents currently serves as President & Director at Allergan, Inc., Celsius Therapeutics, Inc., Oculeve, Inc., and Allergan GI Corp.
He is Chief Financial Officer & Executive Vice President at AbbVie, Inc. since 2022, Chief Financial Officer at Tobira Therapeutics, Inc., Manager at Pharmacyclics LLC, and President at Landos Biopharma, Inc. Formerly, Mr. Reents was President & Director at Cerevel Therapeutics Holdings, Inc. and Vice President-Tax at Abbott Laboratories.
Education includes undergraduate studies at the University of Nebraska and graduate studies including an MBA at the University of Washington.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/03/2026 | 38.777 ( 0% ) | 10 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Direttore Finanziario/CFO | - |
| ABBVIE INC. | Direttore Finanziario/CFO | 23/06/2022 |
| ALLERGAN, INC. | Presidente | - |
| LANDOS BIOPHARMA, INC. | Presidente | - |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Presidente | - |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Presidente | - |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Presidente | - |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
University of Nebraska
University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Landos Biopharma, Inc.
Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale